Under GST law,
the concept of “composite supply”
is still an area of interpretation even
though the government has issued clarifications and FAQs as unique
underlying facts of each case needs to be examined. One
such scenario relates
to the Reagent Rental Contract (“RRC”) which is commonly
entered into by the medical
device companies with hospitals, laboratories etc.
Under this model, the medical instruments are provided
by the companies without any consideration for a specified period to the end customers
such as hospital, laboratories etc., who
in return agrees
to purchase a minimum quantity
of reagents/consumable during
the contract period at agreed
prices. Also, the reagents are procured through their authorised distributor
channels.
The modus operandi
of the transaction under this model is that the movement of the medical instruments are done on the basis
of a delivery challan and the reagents/consumables are supplied at specified prices
by way of issuing a tax invoice
at applicable rate of GST.
With the market
players extensively operating under such business
model and the
GST regime still being
in its evolving phase, the tax implications arising on such transactions is yet to attain
uniformity. As we understand that, in case businesses perceives any doubts, they can opt to
approach the Authority of Advance
Ruling to determine the tax consequences of the particular transaction.
In one such instance, the above transaction was examined
by the Kerala Advance Ruling Authority (‘Kerala AAR’) in the case of M/s Abbott
Healthcare (P.) Ltd. (“company”) [TS-538- AAR-2018-NT], wherein
it was held
that above transaction of placing the medical instruments to unrelated customers like hospitals/laboratories for their use without any consideration, in the
backdrop of an agreement containing minimum purchase obligation of products like
reagents/consumables for a specified period
constituted “composite supply”.
Aggrieved by the above ruling the company
filed an appeal before the Appellate Authority
for Advance Ruling (AAAR)
[TS-917-AAAR-2018-NT] who rejected the appeal of the company
and hence a writ was filed before the Kerala High Court [TS-4-HC-2020(KER)-NT].
In the ensuing
part of this
article, effort has been made
to highlight the
key aspects pronounced by Hon’ble High Court of Kerala.
Brief Facts of the Case
The petitioner is a company
engaged in the sale of pharmaceutical products, diagnostic kits etc. It has executed
Reagent supply and Instrument use agreements with
hospitals and laboratories;
The medical instruments would be provided
to the customer without any consideration
basis and to be placed at his premises;
The stipulation attached
to the such arrangement is that the end customer
will purchase minimum agreed
quantity of reagents/consumables at agreed prices, through its distributors, barring
which, the petitioner was entitled to recover the deficit amount;
The supply of reagents etc. are done by the distributors to the hospital/laboratories are on
a principal to principal basis
by issuing a tax invoice
after levying applicable GST @5%.
Further, it has been highlighted that the value
of instruments in comparison to the total turnover
of supply of reagents/consumables over the contract period, accounted to around
20% of the turnover of reagents etc.
When a consignment of instruments was being transported to a laboratory without any
consideration, the same was seized
by tax officer on the ground that the goods were not accompanied with a tax invoice but were being
transported under a delivery challan.
The question raised
before the Advance
ruling authority (AAR) was whether
provision of medical
instruments by company to unrelated parties ie hospitals and laboratories
constitutes a “ supply” or whether it constitutes “ movement of goods otherwise
than by way of supply” as per
GST Act.
The AAR held that placement of medical instruments to unrelated
customers like hospitals/laboratories for their use without any consideration,
in the backdrop of an agreement containing minimum purchase obligation of products like reagents/consumables
for a specified period constituted “composite supply”. The Appellate Authority
for Advance Ruling (AAAR) rejected the appeal of the company
and hence a writ was filed before
the Kerala High Court.
The Kerala
High Court Decision
Context
The High Court stated that the AAR had opined that the
company had made two supplies, namely of medical instruments and of
reagents/consumables to be used along with the instruments. Since the instruments supplied
had no utility to the customer unless
he also bought the reagents/consumables, the supply
of the instruments and reagents/consumables had to be seen as naturally bundled to form a
composite supply. The AAR went on to observe that the
supply of instrument was to be treated as principal
supply, in the composite supply, and accordingly, that the reagents etc had to
taxed at a higher rate applicable to the instrument supplied. As regards valuation of the said
supply, the AAR found that
in terms of the agreement, the company had, in fact,
supplied the medical instrument for deferred consideration since, according to
it, the minimum purchase obligation in respect of reagents etc, under the
agreement, ensured that
the overall price
realized from customer subsumed within it,
the rent for the
instrument as well.
This was more so because,
the agreement between
the parties clearly stipulated that if the required quantity
of reagents was not purchased
by the customer, it was obliged to pay to the company
the deficient amount.
The aforesaid findings of AAR were
upheld by the AAAR.
Observations
Jurisdiction – The
AAR was required to give a ruling on whether the
placement of medical instruments at the customer premises constitutes a ‘ supply’
under GST Act.
Rather than that the AAR actually
gave a finding that provision of medical instruments to customers constituted a ‘composite supply’. Its this finding,
was wholly without jurisdiction. The AAR went beyond the terms of reference. As a consequence, the AAR did not go into the real
issue of whether placing the instruments per se constituted a taxable supply
under the GST Act.
Nature of supply and valuation thereof – The High Court held that
the concept of enhancement of utility of the instrument through the supply of
reagents/consumables, while relevant for the purposes
of valuation of supply of instruments, cannot
be imported into the concept of composite supply under GST Act. While clubbing of two independent supplies may be resorted
to for the purposes of valuation of each of those supplies, there is no scope of clubbing of two independent supplies so as
to notionally alter the very nature of each of those
supplies as the existed in fact, at the relevant
point in time.
Composite Supply – Since the counsel for the company urged the High
Court to give a definitive view on the transaction being a composite supply, the High Court proceeded to examine the transaction.
It will be apt at this stage
to reproduce the
definition of “ composite supply”
under the GST Act:
“ a supply
made by a
taxable person to a recipient consisting of two or more
taxable supplies of goods
or services or both, or any combination thereof, which are naturally bundled
and supplied in conjunction with each other
in the ordinary course of business, one of which
is the principal supply”.
The High Court held that in order for the supply to be
composite, it has to be made by one taxable person. In the instant
case, the instrument is provided by company and the supply
of reagents/consumables by the distributors who purchase it from the company on a principal to principal basis. Although
it could be argued that
there is a relationship between
the said persons that influences the valuation
of the supply, the same does not take away from the fact that the
supplies are, in reality made
by two different taxable persons.
Indeed supplies by two separate suppliers could not be treated as principal and ancillary supplies.
The High Court
also held that
composite supply must
take into account
supplies as effected at a given point in
time on “ as is where is “ basis.
Next Steps – The writ petition was allowed by quashing the orders of AAR and AAAR and remanding the matter back
for fresh order
to be passed on the basis of observations in this
judgment.
Key Takeaways
from the Decision
Jurisdiction – The AAR/AAAR must only address the question raised by
the applicant. Nature of supply and valuation thereof – It is important to
understand the difference between nature of supply and valuation thereof.
Composite Supply – If there are two taxable persons
involved in a transaction, it cannot
partake the nature of a composite supply. Also, the composite supply must take
into account supplies as effected at a given point in time on “ as is where is “ basis.
Reagent
Rental Contract
It is important to mention that recently there has been a Karnataka
AAR in the case ofM/s Randox
Laboratories India Private Limited [TS-1025-AAR-2019-NT] on facts which are
identical to the facts of the case
of M/s Abbott Healthcare Pvt.
Ltd. The Karnataka AAR held that there will be no tax implication arising on medical
instrument provided to the hospital where no
consideration was received, as the same is outside the purview of supply under
GST. Conclusion
It is interesting to note that
the Hon’ble High
Court has remanded
the matter back
to Kerala AAR for
fresh consideration based on the observations made in the judgment.
Unless challenged in the higher
fora, the said order would provide major relief to the medical device industry, which might
have faced a major impact
in case the of supply
under RRC model, as the entire supply
would have resulted
in levy of tax @ 18% (taking
instruments as a principal
supply) instead of 5%/12% as applicable on the supply of reagents.
Now, it would be interesting to see how the outcome
of the matter after the observations made by
the High Court
of Kerala, whether
the same would
concur with the ruling pronounced by the Karnataka AAR
as in the case of M/s Randox
Laboratories India Private
Limited or would
lead to another round of litigation
A favorable ruling may result in putting rest to a lot of future
litigations on the said matter.
No comments:
Post a Comment